Overview
Clinical Benefits
- Increased muscle mass
- Fat loss
- Improved sleep
- Enhanced recovery
Administration
Subcutaneous injection, ideally before bed
Drug class: ghrh analog
Clinical Dosing
Typical dosage
1-2mg per week
Starting dose
1mg
Cadence
1-2x weekly
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-4 | 1mg once weekly |
| Weeks 5-8 | 1mg twice weekly |
| Weeks 9+ | 2mg once weekly or 1mg twice weekly |
Safety Profile
Side effects
- • Water retention
- • Tingling
- • Fatigue
Contraindications
- • Active cancer
- • Diabetes
- • Insulin resistance
Do not combine with
Cycling guidance
Off: 4 wks
GHRH analog cycling prevents pituitary downregulation
Frequently asked questions
CJC-1295 is most commonly researched for: Increased muscle mass, Fat loss, Improved sleep, Enhanced recovery.
Ready to build a protocol with CJC-1295?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.